Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Izmir Katip Çelebi University Atatürk Training and Research Hospital | Turkey

Dr. Tuncay Kırış, an Associate Professor at İzmir Kâtip Çelebi University, Izmir, Turkey, is a distinguished cardiology researcher recognized for his extensive contributions to cardiovascular medicine, particularly in the fields of cardiovascular risk prediction, interventional cardiology, acute coronary syndromes, and cardiac biomarkers. His research has provided valuable insights into myocardial infarction, pulmonary embolism, renal complications following cardiac interventions, and the prognostic implications of biochemical and hematological markers in predicting patient outcomes. Dr. Tuncay Kırış has authored 83 peer-reviewed publications in prestigious international journals indexed in SCI and SCI-Expanded, including Angiology, BMC Cardiovascular Disorders, The Anatolian Journal of Cardiology, Clinical and Experimental Hypertension, Herz, and Acta Radiologica. His works have received 591 citations from 544 documents, with an h-index of 15, according to Scopus (Author ID: 55321350600), reflecting his strong academic impact. His studies emphasize innovative predictive and prognostic modeling approaches, such as exploring the fibrinogen-to-albumin ratio, red cell distribution width, and lymphocyte-to-monocyte ratio as novel indicators of adverse cardiovascular events and renal complications. Beyond his research, he has supervised postgraduate theses on cardiovascular risk assessment, contributed to collaborative projects in clinical and translational cardiology, and serves as Editor of the Ege Klinikleri Tıp Dergisi. As an active reviewer for several international cardiology journals, Dr. Tuncay Kırış continues to advance evidence-based cardiology through data-driven research, bridging clinical practice with innovation to improve patient outcomes and global cardiovascular health.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  • Yildirim, S. E., Yildirim, T., Kırış, T., & Avci, E. (2025, October). Prognostic value of the NAPLES score and serum uric acid in chronic coronary syndrome: Evidence from time-dependent ROC and time-varying hazard ratio analyses. Journal of Clinical Medicine, 14(20), 7416. https://doi.org/10.3390/jcm14207416

  • Tiryaki, M. M., Yılmaz, C., Ince, H. S., Karaca, B., Kayaalti Esin, F., & Kırış, T. (2025, September). Neutrophil percentage-to-albumin ratio as a predictor of in-hospital mortality in infective endocarditis. Biomarkers in Medicine, 19(17), 1–8. https://doi.org/10.1080/17520363.2025.2562554

  • Akkan, G., Kırış, T., Esin, F., & Karaca, M. (2025, May). Evaluation of mortality and hospitalization due to decompensated heart failure and appropriate shocks in reduced ejection fraction in patients with an implantable cardioverter–defibrillator according to a novel tissue Doppler echocardiographic method. Journal of Clinical Medicine, 14(9), 3226. https://doi.org/10.3390/jcm14093226

  • Esin, F., Bozkurt, H., Palac, B., Akar, B., Kırış, T., Özdemir, E., & Karaca, M. (2025, February). The impact of pleural effusion on long-term mortality in patients undergoing transcatheter aortic valve implantation. Journal of Clinical Medicine, 14(5), 1596. https://doi.org/10.3390/jcm14051596

  • Usta, A., Sancakli Usta, C., Lafci, D., Kırış, T., & Avci, E. (2024, December). Contrast induced nephropathy in women with infertility undergoing hysterosalpingography. Reproductive Biology and Endocrinology, 22(1). https://doi.org/10.1186/s12958-024-01334-3

Zhongzhen Su | Medicine | Best Researcher Award

Published on by Forensic Scientist

Dr. Zhongzhen Su | Medicine | Best Researcher Award

The Fifth Affiliated Hospital of Sun Yat-sen University |China

Dr. Zhongzhen Su is a renowned medical professional with over two decades of expertise in abdominal ultrasound diagnosis and liver cancer interventional therapy. Currently serving as the Director of the Ultrasound Medicine Department at the Fifth Affiliated Hospital of Sun Yat-sen University, he has made pivotal contributions in early liver cancer detection and fibrosis assessment. Recognized as a “High-level Talent in Zhuhai” and a “Guangdong Outstanding Young Medical Talent”, Dr. Su has significantly enhanced survival outcomes for cirrhotic patients through innovative imaging techniques.

Professional profile👤

Scopus

Strengths for the Awards✨

  1. Established Academic and Research Record:

    • 48 SCI publications with an H-index of 28 and 1,000+ citations, indicating consistent and influential contributions.

    • Highest publication impact factor of 14.3, demonstrating recognition in high-quality journals.

  2. Innovative Contributions:

    • Two patents (e.g., tumor ultrasound phantom, fibrosis prediction model) and innovative developments in liver cancer diagnostics and ablation.

    • Led 18 completed and 1 ongoing research projects, including National Natural Science Foundation grants.

  3. Clinical and Educational Impact:

    • Pioneered early detection and ultrasound-guided treatment of liver cancer, improving survival rates.

    • Trained over 50 postgraduates, indicating a significant contribution to academic mentorship.

  4. Recognitions and Leadership:

    • Recognized as a “High-level Talent in Zhuhai” and “Guangdong Outstanding Young Medical Talent”.

    • Serves as Director of Ultrasound Medicine and holds leadership roles in national professional associations.

  5. Interdisciplinary and AI Integration:

    • Engaged in AI-based fibrosis assessment and multicenter collaborations, showcasing forward-looking research alignment.

🎓 Education

Dr. Zhongzhen Su earned his Ph.D. in Imaging and Nuclear Medicine from Sun Yat-sen University, one of China’s top medical institutions. His academic foundation combines clinical depth with scientific rigor, forming the bedrock for his ongoing advancements in ultrasound-guided interventions and diagnostic radiology.

👨‍⚕️ Experience

With over 20 years of clinical and academic experience, Dr. Zhongzhen Su has held key roles, including Deputy Dean of the Fifth Affiliated Hospital and now Director of Ultrasound Medicine. His leadership has been instrumental in establishing state-of-the-art interventional ultrasound programs, supervising over 50 postgraduates, and leading multicenter clinical trials focused on liver health.

🔬 Research Interest On Medicine

Dr. Zhongzhen Su primary research interests lie in abdominal ultrasound diagnosis, interventional ultrasound for liver cancer, quantitative assessment of liver fibrosis, and post-ablation evaluation techniques. He is also exploring AI-based models for early-stage fibrosis and cancer detection, which promise transformative impacts in personalized medicine.

🏆 Awards

Dr. Zhongzhen Su is a three-time recipient of the Guangdong Science and Technology Awards 🏅, reflecting his leadership in ultrasound-guided interventional innovation. He has also been honored as a “High-level Talent in Zhuhai” and a “Guangdong Outstanding Young Medical Talent”, distinctions reserved for top-tier professionals in the region’s medical community.

📚 Publications

1. Nomogram Using Bi-modal Imaging for Predicting Low-level HER2 Expression Status in Breast Cancer

  • Authors: Xingyu Liang, Jiamin Chen, Jiawei Tian, Xin Wen

  • Journal: European Journal of Radiology

  • Year: 2025

2. Combination of CT/MRI LI-RADS With Second-Line Contrast-Enhanced Ultrasound Using Sulfur Hexafluoride or Perfluorobutane for Diagnosing Hepatocellular Carcinoma in High-Risk Patients

  • Authors: Yu Li, Sheng Li, Qing Li, Lingling Li, Jianhua Zhou

  • Journal: Korean Journal of Radiology

  • Year: 2025

  • Citations: 0​

3. Doppler Ultrasound Imaging and Shear Wave Elastography for Evaluation of Interstitial Fibrosis/Tubular Atrophy in IgA Nephropathy

  • Authors: Jiaxin Chen, Shuqing Wang, Qunyan Wu, Zhongzhen Su, Yuhong Lin

  • Journal: Abdominal Radiology

  • Year: 2025

4. Tertiary Lymphoid Structure Formation Induced by LIGHT-Engineered and Photosensitive Nanoparticles-Decorated Bacteria Enhances Immune Response Against Colorectal Cancer

  • Authors: Lijun Hu, Li Tan, Shaohui Deng, Honglin Gao, Yujie Jiang, Chen Qiu, Hui Chen, Zecong Xiao, Xintao Shuai, Zhongzhen Su

  • Journal: Biomaterials

  • Year: 2025

  • Citations: 6​

5. Histopathological Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma: Is It Reliable?

  • Authors: Liujun Li, Chaoqun Wu, Feile Ye, Zhou Xuan, Xiaoli Zhang, Jianping Li, Jia Zhou, Zhongzhen Su

  • Journal: World Journal of Gastroenterology

  • Year: 2025

6. Radiomics Diagnosis of Microvascular Invasion in Hepatocellular Carcinoma Using 3D Ultrasound and Whole-Slide Image Fusion

  • Authors: Liujun Li, Shaodong Wang, Jiaxin Chen, Yao Lu, Zhongzhen Su

  • Journal: Small Methods

  • Year: 2025

7. Model Based on Ultrasound and Clinicopathological Characteristics for Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

  • Authors: Xin Wen, Jiamin Chen, Jing Zhong, Yuhong Lin, Zhongzhen Su

  • Journal: Quantitative Imaging in Medicine and Surgery

  • Year: 2024

  • Citations: 1​

8. Development and Validation of an Individualized Nomogram for Predicting Patent Foramen Ovale-Associated Stroke: Patent Foramen Ovale Morphology-Based Analysis

  • Authors: Qin Zhang, Mochao Xiao, Wuzhu Lu, Zhongzhen Su, Xiaobo Chen

  • Journal: Echocardiography

  • Year: 2024

🧾 Conclusion

In summary, Dr. Zhongzhen Su stands out as a visionary ultrasound expert and medical educator, having redefined interventional standards in liver cancer therapy and fibrosis evaluation. His trailblazing research, prolific publication record, and dedication to clinical excellence make him an ideal nominee for the Best Researcher Award at the FORENSIC SCIENTIST AWARDS. 🏅🔍